Abstract:Abstract Background Drug-disease associations (DDAs) can provide important information for exploring the potential efficacy of drugs. However, up to now, there are still few DDAs verified by experiments. Previous evidence indicates that the combination of information would be conducive to the discovery of new DDAs. How to integrate different biological data sources and identify the most effective drugs for a certain disease based on drug-disease coupled mechanisms is still a challenging problem. Results In this paper, we proposed a novel computation model for DDA predictions based on graph representation learning over multi-biomolecular network (GRLMN). More specifically, we firstly constructed a large-scale molecular association network (MAN) by integrating the associations among drugs, diseases, proteins, miRNAs, and lncRNAs. Then, a graph embedding model was used to learn vector representations for all drugs and diseases in MAN. Finally, the combined features were fed to a random forest (RF) model to predict new DDAs. The proposed model was evaluated on the SCMFDD-S data set using five-fold cross-validation. Experiment results showed that GRLMN model was very accurate with the area under the ROC curve (AUC) of 87.9%, which outperformed all previous works in terms of both accuracy and AUC in benchmark dataset. To further verify the high performance of GRLMN, we carried out two case studies for two common diseases. As a result, in the ranking of drugs that were predicted to be related to certain diseases (such as kidney disease and fever), 15 of the top 20 drugs have been experimentally confirmed. Conclusions The experimental results show that our model has good performance in the prediction of DDA. GRLMN is an effective prioritization tool for screening the reliable DDAs for follow-up studies concerning their participation in drug reposition.

A robust drug representation learning model for eliminating cell specificity in gene expression profile and its application.

DRLM: A Robust Drug Representation Learning Method and Its Applications

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

Drug Sensitivity Prediction Based on Multi-stage Multi-modal Drug Representation Learning

Deep generative neural network for accurate drug response imputation

Boosting drug-disease association prediction for drug repositioning via dual-feature extraction and cross-dual-domain decoding

GADRP: graph convolutional networks and autoencoders for cancer drug response prediction

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

Predicting Drug-Disease Associations Via Using Gaussian Interaction Profile and Kernel-Based Autoencoder

Decoding Drug Response with Structurized Gridding Map-based Cell Representation.

A Genetic Algorithm-Based Ensemble Learning Framework for Drug Combination Prediction

GSDRP: Fusing Drug Sequence Features with Graph Features to Predict Drug Response

A Novel Approach For Drug Response Prediction In Cancer Cell Lines Via Network Representation Learning

DeepCDR: a Hybrid Graph Convolutional Network for Predicting Cancer Drug Response

DRUGSYNC: Prediction of Synergistic Drug Combinations Using GCN Graph Convolutional Network based and Pre-learned Drug-induced Gene Expression Profiles

Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity

An Enhanced Cascade-Based Deep Forest Model for Drug Combination Prediction

MSResG: Using GAE and Residual GCN to Predict Drug–Drug Interactions Based on Multi-source Drug Features

MGRL: Predicting Drug-Disease Associations Based on Multi-Graph Representation Learning

Hypergraph Representation Learning for Cancer Drug Response Prediction

Learning the Cellular Activity Representation Based on Gene Regulatory Networks for Prediction of Tumor Response to Drugs